z-logo
open-access-imgOpen Access
Perioperative chemotherapy for muscle-invasive bladder cancer
Author(s) -
Peter C. Black,
Alan So
Publication year - 2013
Publication title -
canadian urological association journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.477
H-Index - 38
eISSN - 1920-1214
pISSN - 1911-6470
DOI - 10.5489/cuaj.1202
Subject(s) - cystectomy , medicine , bladder cancer , perioperative , chemotherapy , adjuvant chemotherapy , adjuvant , surgery , cancer , general surgery , oncology , breast cancer
Considerable debate exists concerning the combined use of systemicchemotherapy and radical surgery for muscle-invasive bladdercancer. While there is evidence for a survival benefit afterneoadjuvant chemotherapy, the benefit is modest and the potentialtoxicity and delay of time to surgery prior to cystectomy appearsto be deterring many surgeons from its administration. The evidencefor adjuvant chemotherapy, on the other hand, is less compellingand substantial. Furthermore, the role of adjuvant comparedto salvage chemotherapy requires further investigation.Similarly, research continues on identifying molecular and clinicalmarkers to best stratify patients for optimal perioperative therapy.In this article, the evidence for radical cystectomy andchemotherapy, given either in a neoadjuvant or adjuvant setting,will be reviewed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here